Adjunct faculty typically have an academic or research appointment at another institution and contribute or collaborate with one or more School of Medicine faculty members or programs.
Adjunct rank detailsBadr Al Bawardy, MD
Assistant Professor Adjunct of Medicine (Digestive Diseases)About
Copy Link
Titles
Assistant Professor Adjunct of Medicine (Digestive Diseases)
Biography
Badr Al Bawardy, MD, is a gastroenterologist at Yale Medicine specializing in inflammatory bowel disease (IBD), Crohn’s disease, and ulcerative colitis. He performs the following procedures: esophagogastroduodenoscopy (a diagnostic endoscopic procedure for the upper digestive tract, also known as EGD), colonoscopy, chromoendoscopy, and video capsule endoscopy.
Dr. Al Bawardy earned his M.D. with distinction from the George Washington University. After medical school, he completed an internal medicine residency, gastroenterology fellowship and a specialized inflammatory bowel disease fellowship at the Mayo Clinic in Rochester, MN, which gave him valuable experience treating the disease alongside leaders in the field.
IBD is a chronic medical condition affecting the gut, and often requires doctors to build long-term relationships with patients to manage their care. This type of medical care was appealing to Dr. Al Bawardy. He is a proponent of shared decision making in management of IBD. When meeting patients, Dr. Al Bawardy discusses risks, benefits, and goals of treatment with his patients so they can make an informed decision about their care. He also asks them about their preferences related to lifestyle and career, for example. He takes all this information into account when developing a treatment plan.
“My patient-care philosophy is that the patient always comes first,” he says.
In addition to caring for IBD patients, Dr. Al Bawardy’s clinical interests include evaluating and treating patients with celiac disease, microscopic colitis and general gastroenterology. Dr. Al Bawardy also conducts research and is an assistant professor of medicine (digestive diseases) at Yale School of Medicine.
Appointments
Digestive Diseases
Assistant Professor AdjunctPrimary
Other Departments & Organizations
- Digestive Diseases
- Internal Medicine
- Spondyloarthritis Program
- Yale Inflammatory Bowel Disease Center
- Yale Medicine
Education & Training
- IBD Fellow
- Mayo Clinic (2018)
- Fellow
- Mayo Clinic (2017)
- Resident
- Mayo Clinic (2014)
- MD
- The George Washington University (2011)
Research
Copy Link
Overview
Medical Research Interests
ORCID
0000-0002-6102-9267
Research at a Glance
Yale Co-Authors
Publications Timeline
Research Interests
Deborah Proctor, MD
Jill Gaidos, MD
Marie Robert, MD
Alyssa Ann Grimshaw, MBA, MLIS, MPH
Kenneth Hung, MD, MS
Louis Levine, MD, MEd
Inflammatory Bowel Diseases
Crohn Disease
Treatment Outcome
Colitis, Ulcerative
Publications
2025
Utilisation and real-world effectiveness of advanced therapies for inflammatory bowel disease in Middle Eastern populations: a systematic review
Quraishi M, Alahmad M, Sharara A, Trivedi P, Al-Bawardy B, Alrubaiy L. Utilisation and real-world effectiveness of advanced therapies for inflammatory bowel disease in Middle Eastern populations: a systematic review. BMJ Open Gastroenterology 2025, 12: e002034. PMID: 41330599, PMCID: PMC12673545, DOI: 10.1136/bmjgast-2025-002034.Peer-Reviewed Original ResearchAltmetricMeSH Keywords and ConceptsConceptsInflammatory bowel diseaseRemission rateCochrane Central RegisterAdvanced therapiesClinical remissionCrohn's diseaseOdds of treatment failureUlcerative colitisBowel diseaseMiddle Eastern populationsControlled TrialsEndoscopic remission ratesBiologic-naive patientsClinical remission rateCochrane Central Register of Controlled TrialsReal-world evidenceCentral Register of Controlled TrialsRegister of Controlled TrialsReal-world effectivenessSaudi studiesMiddle Eastern cohortNewer agentsTreatment failureRandomised controlled trialsStudy designInitial Management of Intra-Abdominal Abscess in Crohn’s Disease: A Systematic Review and Meta-Analysis
Quraishi M, Al Ahmad M, Al Ali N, Church R, Al-Bawardy B. Initial Management of Intra-Abdominal Abscess in Crohn’s Disease: A Systematic Review and Meta-Analysis. Inflammatory Bowel Diseases 2025, izaf242. PMID: 41211676, DOI: 10.1093/ibd/izaf242.Peer-Reviewed Original ResearchAltmetricConceptsIntra-abdominal abscessComplication of Crohn's diseaseInitial surgeryReoperation rateMedical managementPostinterventional complicationsSurgical interventionManagement of intra-abdominal abscessesCrohn's diseaseSystematic reviewExclusive enteral nutritionLow reoperation rateBridge to surgeryAssociated with significantly lower oddsMeta-analysisAssociated with significantly higher oddsSignificantly higher oddsSignificantly lower oddsRandom-effects modelLength of stayEnteral nutritionSurgery groupDefinitive treatmentSurgical groupSurgical managementPrevalence and Impact of Zinc Deficiency on Clinical Outcomes in Inflammatory Bowel Disease
Almuhaya H, Alsalamah R, Sallam A, Alonazy A, AlAwwad A, Mohamed G, Almutairdi A, Attamimi M, Al-Bawardy B. Prevalence and Impact of Zinc Deficiency on Clinical Outcomes in Inflammatory Bowel Disease. Nutrients 2025, 17: 3378. PMID: 41228451, PMCID: PMC12610508, DOI: 10.3390/nu17213378.Peer-Reviewed Original ResearchMeSH Keywords and ConceptsConceptsInflammatory bowel diseaseIBD-related hospitalizationImpact of zinc deficiencyZinc deficiencyRetrospective studyClinical outcomesClinical profileEmergency room visitsMethods:Prevalence of zinc deficiencyClinical profile of patientsBowel diseaseResults:Inflammatory bowel disease patientsZinc-deficient patientsIBD-related surgeryAssociated with higher ratesC-reactive proteinMarkers of inflammationProfile of patientsRoom visitsFecal calprotectinLow albuminInflammatory burdenClinical characteristicsS2001 Assessment of Sociodemographic Factors and Outcomes of Ulcerative Colitis Hospitalizations: A Large Population-Based Study
Sahyoun L, Li D, Al Bawardy B. S2001 Assessment of Sociodemographic Factors and Outcomes of Ulcerative Colitis Hospitalizations: A Large Population-Based Study. The American Journal Of Gastroenterology 2025, 120: s429-s429. DOI: 10.14309/01.ajg.0001135464.36795.f0.Peer-Reviewed Original ResearchS1935 Advanced Combination Therapy of Upadacitinib and Biologic Therapy in Refractory Inflammatory Bowel Disease Patients
Alkarni W, Almuhaya H, Alrossais N, Desai S, Almutairdi A, Al Bawardy B, Attamimi M. S1935 Advanced Combination Therapy of Upadacitinib and Biologic Therapy in Refractory Inflammatory Bowel Disease Patients. The American Journal Of Gastroenterology 2025, 120: s415-s415. DOI: 10.14309/01.ajg.0001135200.71215.74.Peer-Reviewed Original ResearchS1625 Sex Differences in Cardiovascular and Venous Thromboembolic Complications in Inflammatory Bowel Disease: A Large Multicenter Study
Aljohani R, Abualnaja A, Attamimi M, Almutairdi A, Alrajhi E, Nawaz A, Al Bawardy B. S1625 Sex Differences in Cardiovascular and Venous Thromboembolic Complications in Inflammatory Bowel Disease: A Large Multicenter Study. The American Journal Of Gastroenterology 2025, 120: s349-s349. DOI: 10.14309/01.ajg.0001133960.41734.57.Peer-Reviewed Original ResearchS2033 Impact of Positive Family History on Outcomes in Inflammatory Bowel Disease
Aldahash B, Al Bawardy B, Alshareef A, Elsayed M, Desai S, Almutairdi A, Attamimi M. S2033 Impact of Positive Family History on Outcomes in Inflammatory Bowel Disease. The American Journal Of Gastroenterology 2025, 120: s436-s436. DOI: 10.14309/01.ajg.0001135592.82168.fc.Peer-Reviewed Original ResearchS1569 Impact of Delayed Diagnosis on Outcomes in Inflammatory Bowel Disease (IBD)
Almuammar S, Al Bawardy B, Alyahya L, Mahmoud W, Almutairdi A, Attamimi M, Desai S. S1569 Impact of Delayed Diagnosis on Outcomes in Inflammatory Bowel Disease (IBD). The American Journal Of Gastroenterology 2025, 120: s337-s338. DOI: 10.14309/01.ajg.0001133736.47558.f2.Peer-Reviewed Original ResearchS2031 Incremental Improvement in Bowel Urgency Was Associated With Improved Patient-Reported Outcomes: Post Hoc Results From LUCENT-1 and -2 Trials
Dubinsky M, Travis S, Wu J, Zhu B, Qiu H, Mosby C, Folian S, Kobayashi T, Al Bawardy B, Rubin D. S2031 Incremental Improvement in Bowel Urgency Was Associated With Improved Patient-Reported Outcomes: Post Hoc Results From LUCENT-1 and -2 Trials. The American Journal Of Gastroenterology 2025, 120: s436-s436. DOI: 10.14309/01.ajg.0001135584.98064.1f.Peer-Reviewed Original ResearchEditorial: Redefining Safety in Post‐Liver Transplant IBD—Why Therapeutic Effectiveness Is the Ultimate Shield
Quraishi M, Al‐Bawardy B. Editorial: Redefining Safety in Post‐Liver Transplant IBD—Why Therapeutic Effectiveness Is the Ultimate Shield. Alimentary Pharmacology & Therapeutics 2025, 62: 1040-1041. PMID: 40820804, DOI: 10.1111/apt.70310.Peer-Reviewed Original ResearchCitations
Academic Achievements & Community Involvement
Copy Link
Honors
honor Healthcare Honored Hero
05/01/2021Regional AwardCrohn's and Colitis Foundation, Connecticut/Westchester ChapterDetailsUnited Stateshonor Young Investigator Travel Grant Award
01/01/2020National AwardCrohn's and Colitis FoundationDetailsUnited Stateshonor Howard M. Spiro Fellowship Teaching Award
06/18/2019Yale School of Medicine AwardDigestive Diseases, Yale School of MedicineDetailsUnited Stateshonor Edward C Rosenow Award
05/01/2018Regional AwardDepartment of Internal Medicine. Mayo Clinic, Rochester, MNDetailsUnited Stateshonor Travel Grant Award
12/01/2017National AwardAdvances in Inflammatory Bowel Diseases ConferenceDetailsUnited States
News
Copy Link
News
- August 10, 2023
Ulcerative Colitis: Early Sigmoidoscopy & Clinical Outcomes (Discoveries & Impact August 2023)
- July 13, 2023
Oral Vancomycin as a Treatment Option for Primary Sclerosing Cholangitis-associated Inflammatory Bowel Disease (Discoveries & Impact July 2023)
- June 05, 2023
Yale Digestive Diseases Shares Latest Research in Chicago
- April 13, 2023
Discoveries & Impact (April 2023)